X-103274468-A-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001012979.3(TCEAL5):c.96T>A(p.Asp32Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000447 in 1,207,632 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 21 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001012979.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TCEAL5 | NM_001012979.3 | c.96T>A | p.Asp32Glu | missense_variant | 3/3 | ENST00000372680.2 | NP_001012997.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCEAL5 | ENST00000372680.2 | c.96T>A | p.Asp32Glu | missense_variant | 3/3 | 1 | NM_001012979.3 | ENSP00000361765 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 26AN: 109771Hom.: 0 Cov.: 22 AF XY: 0.000279 AC XY: 9AN XY: 32247
GnomAD3 exomes AF: 0.0000940 AC: 17AN: 180907Hom.: 0 AF XY: 0.0000908 AC XY: 6AN XY: 66105
GnomAD4 exome AF: 0.0000255 AC: 28AN: 1097861Hom.: 0 Cov.: 32 AF XY: 0.0000330 AC XY: 12AN XY: 363289
GnomAD4 genome AF: 0.000237 AC: 26AN: 109771Hom.: 0 Cov.: 22 AF XY: 0.000279 AC XY: 9AN XY: 32247
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2023 | The c.96T>A (p.D32E) alteration is located in exon 3 (coding exon 1) of the TCEAL5 gene. This alteration results from a T to A substitution at nucleotide position 96, causing the aspartic acid (D) at amino acid position 32 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at